2m 2m 2m 2m 2m 2m 2m
RANI THERAP-A (RANI)
NASDAQ
$0.64+$0.005 (+0.85%)
Price as of Jul 14, 2026 8:30 AM EDT- $71.1MMarket Cap
- -9.42%1-Year Change
- BiotechnologyIndustry
RANI THERAP-A (RANI)
$0.64+$0.005 (+0.85%)
RANI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.63 | ||
Change | -$0.05 (-7.95%) | ||
Open | $0.69 | ||
High | $0.70 | ||
Low | $0.61 | ||
Previous Close | $0.69 | ||
Volume | 1,118,391 | ||
30-Day Average Volume | 678,581 | ||
1-Week Change | -20.23% | ||
1-Month Change | -16.77% | ||
1-Year Change | -9.42% | ||
3-Year Change | -85.46% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 112.4M | ||
Total Assets | $51.9M | ||
Market Cap | $71.1M | ||
Enterprise Value | $61.5M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$7.0M | ||
Free Cash Flow | -$6.5M | ||
EBIT | -$6.9M | ||
EBITDA | -$6.8M | ||
Net Working Capital | $33.2M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 3 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue